Lyra Therapeutics Inc.
- Address
- 480 Arsenal Way
Sponsor Overview
Specializations
Chronic Rhinosinusitis in Adults
Clinical research activity is centered on chronic rhinosinusitis in adult patients, with attention to persistent sinonasal symptoms and treatment-resistant disease. The trial portfolio reflects interest in CRS without nasal polyps and in patients who have not responded adequately to prior medical management.
- Sinonasal symptom control
- Adult chronic sinusitis
- Non-polypoid CRS
The sponsor’s research focus in this area is tied to improving the core symptom burden of chronic sinus disease and addressing unmet needs in adults with ongoing nasal and sinus inflammation.
Otolaryngology and Upper Airway Disease
The funded studies fall within otolaryngology, with emphasis on disorders of the upper airway and sinonasal tract. The clinical landscape includes evaluation of interventions intended to relieve congestion, discharge, and facial pressure associated with chronic sinus conditions.
- Sinonasal inflammation
- Nasal obstruction
- Upper airway symptom relief
Research activity in this domain aligns with the management of chronic ENT conditions that persist despite standard therapy.
Tolerability and Local Treatment Delivery
Clinical interest also extends to the tolerability of locally delivered therapy for chronic sinus disease, with attention to patient experience and treatment acceptability in the nasal cavity and sinus passages.
- Local drug delivery
- Nasal tolerability
- Patient-reported symptom improvement
This area reflects a focus on therapies designed for direct action at the site of disease in chronic sinonasal conditions.
Refractory Sinus Disease
The sponsor’s clinical research includes adults with refractory sinus disease, particularly those who have previously failed medical management. The therapeutic interest is concentrated on persistent disease that continues after conventional treatment approaches.
- Treatment-resistant CRS
- Failed prior therapy
- Persistent cardinal symptoms
Work in this setting is directed toward symptom-focused care for patients with chronic sinonasal disease that remains difficult to manage.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of LYR-210 and Dexamethasone in Adults with Chronic Rhinosinusitis Without Nasal Polyps: A Randomized, Blinded, Controlled Phase III Trial |  Belgium Bulgaria Germany Hungary Poland | Not Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 26 sites across their trial portfolio.
Therapeutic Focus
- 1.Bacterial Infections and Mycoses1 trial180 other sponsors
Partnered Research Centres
26 centres- Address
- Maglodi Ut 89-91, Kerulet, 1106 Budapest
- Address
- Uzsoki Utca 29-41, 1145 Budapest
- Address
- Hippokrateslaan 10, Batiment 54, 1200 Woluwe-Saint-Lambert
- Address
- Tetenyi Ut 12-16, XI Kerulet, 1115 Budapest
- Address
- Bulevard Republika 15, 9020 Varna
- Address
- Ul. Prezydenta Gabriela Narutowicza 24, 88-100 Inowrocław
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Lyra Therapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.